These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6446879)

  • 1. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):743-9. PubMed ID: 6446879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry A; Thornsberry C
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
    Vanhoof R; Nyssen HJ; Nulens E; Roebben E; Hubrechts JM
    Pathol Biol (Paris); 1990 Jun; 38(6):634-7. PubMed ID: 2165238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro of cefotaxime against cephalothin-resistant clinical isolates.
    Van Landuyt HW; Pyckavet M
    Antimicrob Agents Chemother; 1979 Jul; 16(1):109-11. PubMed ID: 475369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1977 Jul; 12(1):47-50. PubMed ID: 883818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of five cephalosporins.
    Mutton KJ; Harkness JL
    Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA
    Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
    Welch DF; Matsen JM
    Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
    Trager GM; White GW; Zimelis VM; Bryk DA; Panwalker AP
    Chemotherapy; 1981; 27(1):34-8. PubMed ID: 6260435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA
    Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
    Bayer AS; Eisenstadt R; Morrison JO
    Antimicrob Agents Chemother; 1984 Jun; 25(6):725-8. PubMed ID: 6331297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.